FDC Limited recalls Timolol Maleate Ophthalmic Solution 0.5% bottles with yellow spike from cap. Defective containers may cause injury during use. Stop using and contact for return.
“FDC Limited Timolol Ophthalmic Solution 0.5% Recall: Yellow Spike Risk.” GovInfoNow, updated September 23, 2026. https://govinfonow.com/recall/32706-fdc-limited-timolol-ophthalmic-solution-0-5-recall-yellow-spike. Based on FDA recall #D-0488-2024 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0488-2024%22&limit=1).
The FDA announced on April 25, 2024, that FDC Limited voluntarily recalled Timolol Maleate Ophthalmic Solution, USP, 0.5%, due to a defective container hazard. The agency reported that yellow-colored spikes from the cap were lodged in the nozzle of the bottles.
Sizes/NDCs: 5mL bottles (NDC 64980-514-05), 15 mL bottles (NDC 64980-514-15)
Lot Codes/Expiry: Lot #083H008 (Exp. 07/2025), 083G003 (Exp. 06/2025), 083J017 (Exp. 09/2025), 083I013 (Exp. 08/2025)
Distribution: New Jersey Only
Units Affected: 382,104
The hazard
The recall addresses a defective container where a yellow-colored spike from the cap is lodged in the nozzle. The firm received several complaints from customers regarding this issue.
Context
GovInfoNow's records show FDC Limited has 10 other recalls on record since July 18, 2024. Other recent recalls of similar products include FDC Limited Timolol Ophthalmic Solution 0.5% Recall (July 5, 2025), FDC Limited Timolol Ophthalmic Solution 10mL Recall (April 18, 2025), and FDC Limited recalls Ciprofloxacin Ophthalmic Solution (March 11, 2025). Other recent recalls of similar products include Micro Labs Dorzolamide/Timolol Eye Drops Recall (July 22, 2026), Apotex Desmopressin Nasal Spray Recall (April 8, 2026), and Lupin Liraglutide 18mg/3mL Injection Recall (April 24, 2026).
How to tell if you have this one
Check for 5mL bottles (NDC 64980-514-05) or 15mL bottles (NDC 64980-514-15) with lot numbers 083H008, 083G003, 083J017, or 083I013. The product is prescription-only and sold through Rising Pharmaceuticals.
Brand
FDC Limited
Category
Drug
Based on the official FDA remedy
What to do — step by step
Stop Using Now
Immediately stop using the recalled Timolol Maleate Ophthalmic Solution bottles with the described defect.
Where it went and when
Where it was distributed
Distributed in New Jersey.
Listed by the agency
Not listed
FDA distribution: “New Jersey Only” States read from FDA’s own wording; “not listed” means the notice does not name it.
States: New Jersey.
Recall timeline
FDA terminated this recall 2.1 years after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0488-2024 (April 25, 2024) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0488-2024 to see it in context.
Plain-language summary written by qwen3:4b on September 23, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.